The IGF@ titration group had significantly lower height gain ( @ SDS , s.d. @ ) during the second year of the randomised trial compared with the high-dose group ( @ SDS , s.d. @ ) , but not significantly lower than the low-dose group ( @ SDS , s.d. @ ; P = @ ) .